Located on Chromosome 11, this mutation impacts HRAS, LRRC56 (HRas proto-oncogene, GTPase| leucine rich repeat containing 56). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any?
Pathogenic; Noonan syndrome and Noonan-related syndrome